Can-Fite BioPharma Ltd. (CANF) Operating margin 2017–2025
Can-Fite BioPharma Ltd. (CANF) operating margin by fiscal year — reported operating income divided by reported revenue.
-2456.8%FY2025 · since FY2017: -910.6% → -2456.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2456.8% | -1250.6 pp |
| FY2024 | -1206.2% | -103.3 pp |
| FY2023 | -1103.0% | +143.5 pp |
| FY2022 | -1246.4% | +259.1 pp |
| FY2021 | -1505.5% | +347.6 pp |
| FY2020 | -1853.1% | -1262.2 pp |
| FY2019 | -590.9% | -449.2 pp |
| FY2018 | -141.7% | +768.9 pp |
| FY2017 | -910.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice